• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用数字化组织病理学图像分析具有不同突变谱的星形细胞瘤的细胞特征差异

Analysis of Cellular Feature Differences of Astrocytomas with Distinct Mutational Profiles Using Digitized Histopathology Images.

作者信息

Roy Mousumi, Wang Fusheng, Teodoro George, Vega Jose Velazqeuz, Brat Daniel, Kong Jun

出版信息

Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:4644-4647. doi: 10.1109/EMBC.2018.8513157.

DOI:10.1109/EMBC.2018.8513157
PMID:30441386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7363437/
Abstract

Cellular phenotypic features derived from histopathology images are the basis of pathologic diagnosis and are thought to be related to underlying molecular profiles. Due to overwhelming cell numbers and population heterogeneity, it remains challenging to quantitatively compute and compare features of cells with distinct molecular signatures. In this study, we propose a self-reliant and efficient analysis framework that supports quantitative analysis of cellular phenotypic difference across distinct molecular groups. To demonstrate efficacy, we quantitatively analyze astrocytomas that are molecularly characterized as either Isocitrate Dehydrogenase (IDH) mutant (MUT) or wildtype (WT) using imaging data from The Cancer Genome Atlas database. Representative cell instances that are phenotypically different between these two groups are retrieved after segmentation, feature computation, data pruning, dimensionality reduction, and unsupervised clustering. Our analysis is generic and can be applied to a wide set of cell-based biomedical research.

摘要

源自组织病理学图像的细胞表型特征是病理诊断的基础,并且被认为与潜在的分子图谱相关。由于细胞数量众多且群体异质性强,对具有不同分子特征的细胞特征进行定量计算和比较仍然具有挑战性。在本研究中,我们提出了一个自主且高效的分析框架,该框架支持对不同分子组之间的细胞表型差异进行定量分析。为了证明其有效性,我们使用来自癌症基因组图谱数据库的成像数据,对分子特征为异柠檬酸脱氢酶(IDH)突变型(MUT)或野生型(WT)的星形细胞瘤进行定量分析。在分割、特征计算、数据修剪、降维和无监督聚类之后,检索出这两组之间表型不同的代表性细胞实例。我们的分析具有通用性,可应用于广泛的基于细胞的生物医学研究。

相似文献

1
Analysis of Cellular Feature Differences of Astrocytomas with Distinct Mutational Profiles Using Digitized Histopathology Images.利用数字化组织病理学图像分析具有不同突变谱的星形细胞瘤的细胞特征差异
Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:4644-4647. doi: 10.1109/EMBC.2018.8513157.
2
Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.建立 II/III 级星形细胞瘤的磁共振成像和临床特征模型,以预测 IDH 突变状态。
Eur J Radiol. 2019 May;114:120-127. doi: 10.1016/j.ejrad.2019.03.003. Epub 2019 Mar 14.
3
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas.包含CCND2的12号染色体短臂增益与异柠檬酸脱氢酶(IDH)突变型星形细胞瘤中的肥胖型组织学相关。
Acta Neuropathol. 2017 Feb;133(2):325-327. doi: 10.1007/s00401-016-1657-7. Epub 2016 Dec 20.
4
Mitotic Index Thresholds Do Not Predict Clinical Outcome for IDH-Mutant Astrocytoma.有丝分裂指数阈值不能预测 IDH 突变型星形细胞瘤的临床结局。
J Neuropathol Exp Neurol. 2019 Nov 1;78(11):1002-1010. doi: 10.1093/jnen/nlz082.
5
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.cIMPACT-NOW更新5:IDH突变型星形细胞瘤的推荐分级标准和术语
Acta Neuropathol. 2020 Mar;139(3):603-608. doi: 10.1007/s00401-020-02127-9. Epub 2020 Jan 29.
6
Integrated molecular characterization of IDH-mutant glioblastomas.IDH 突变型 glioblastomas 的综合分子特征。
Neuropathol Appl Neurobiol. 2019 Feb;45(2):108-118. doi: 10.1111/nan.12523. Epub 2018 Nov 15.
7
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.新型改良的 IDH 突变型星形细胞瘤分级系统。
Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23.
8
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.PROX1是一种用于高级别星形细胞瘤的新型通路特异性预后生物标志物;来自按年龄和异柠檬酸脱氢酶(IDH)突变状态分层的独立胶质母细胞瘤队列的结果。
Oncotarget. 2016 Nov 8;7(45):72431-72442. doi: 10.18632/oncotarget.11957.
9
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.具有上皮样特征的间变性星形细胞瘤,一种新的 IDH 野生型神经胶质瘤分子类型,具有反复出现的 MAPK 通路、CDKN2A/B 和 ATRX 改变。
Acta Neuropathol. 2018 Aug;136(2):273-291. doi: 10.1007/s00401-018-1837-8. Epub 2018 Mar 21.
10
IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.异柠檬酸脱氢酶1(IDH1)突变可存在于10岁以下幼儿的弥漫性星形细胞瘤和巨细胞胶质母细胞瘤中。
Acta Neuropathol. 2016 Jul;132(1):153-5. doi: 10.1007/s00401-016-1579-4. Epub 2016 May 9.

本文引用的文献

1
Robust Nucleus/Cell Detection and Segmentation in Digital Pathology and Microscopy Images: A Comprehensive Review.在数字病理学和显微镜图像中进行稳健的细胞核/细胞检测和分割:全面综述。
IEEE Rev Biomed Eng. 2016;9:234-63. doi: 10.1109/RBME.2016.2515127. Epub 2016 Jan 6.
2
OpenSlide: A vendor-neutral software foundation for digital pathology.OpenSlide:一个用于数字病理学的供应商中立软件基础。
J Pathol Inform. 2013 Sep 27;4:27. doi: 10.4103/2153-3539.119005. eCollection 2013.
3
Decoding information in cell shape.解析细胞形态中的信息。
Cell. 2013 Sep 12;154(6):1356-69. doi: 10.1016/j.cell.2013.08.026.
4
The definition of primary and secondary glioblastoma.原发性和继发性胶质母细胞瘤的定义。
Clin Cancer Res. 2013 Feb 15;19(4):764-72. doi: 10.1158/1078-0432.CCR-12-3002. Epub 2012 Dec 3.
5
Prognostic value of automatically extracted nuclear morphometric features in whole slide images of male breast cancer.男性乳腺癌全切片图像中自动提取核形态计量特征的预后价值。
Mod Pathol. 2012 Dec;25(12):1559-65. doi: 10.1038/modpathol.2012.126. Epub 2012 Aug 17.
6
Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.乳腺癌组织学切片中细胞核形态测量与临床病理特征及预后的相关性
Anticancer Res. 2009 May;29(5):1771-6.
7
Quantification of histochemical staining by color deconvolution.通过颜色反卷积对组织化学染色进行定量分析。
Anal Quant Cytol Histol. 2001 Aug;23(4):291-9.